Insider · CIK 0001337798

Cole G Bradley

Reports to the SEC for 4 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001337798

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-29	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−3,673 sh	$81.43	−$299K	11,672
2026-07-29	KNSAKiniksa Pharmaceuticals International, plcG Gift	Director	GGift	−4,500 sh	—	—	7,172
2026-05-29	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+12.2K sh	—	—	12,158
2026-05-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+2,026 sh	—	—	2,026
2026-05-29	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+2,799 sh	—	—	15,345
2026-05-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,799 sh	—	—	0
2026-05-28	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+11.8K sh	—	—	11,766
2026-05-22	CSTLCASTLE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+13.7K sh	—	—	32,976
2026-05-22	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−13.7K sh	—	—	0
2026-03-05	CSTLCASTLE BIOSCIENCES INCS Sale	Director	SSale	−2,655 sh	$28.51	−$75.7K	19,309
2026-03-05	CSTLCASTLE BIOSCIENCES INC · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,748 sh	—	—	20,000
2026-03-05	CSTLCASTLE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+4,748 sh	$3.38	+$16K	26,712
2026-03-05	CSTLCASTLE BIOSCIENCES INCS Sale	Director	SSale	−4,748 sh	$28.44	−$135K	21,964
2025-06-05	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,173 sh	—	—	0
2025-06-05	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+3,173 sh	—	—	12,546
2025-06-03	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+2,799 sh	—	—	2,799
2025-06-03	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+16.8K sh	—	—	16,798
2025-05-22	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+13.7K sh	—	—	13,667
2025-05-21	CSTLCASTLE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+8,673 sh	—	—	21,964
2025-05-21	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,673 sh	—	—	0
2024-06-06	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+4,373 sh	—	—	9,373
2024-06-06	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,373 sh	—	—	0
2024-06-05	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+19K sh	—	—	19,040
2024-06-05	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+3,173 sh	—	—	3,173
2024-05-25	CSTLCASTLE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+8,636 sh	—	—	13,291
2024-05-25	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,636 sh	—	—	0
2024-05-23	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+8,673 sh	—	—	8,673
2023-06-29	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	—	—	5,000
2023-06-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2023-06-06	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+26.2K sh	—	—	26,236
2023-06-06	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+4,373 sh	—	—	4,373
2023-06-02	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,825 sh	—	—	0
2023-06-02	CSTLCASTLE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+3,825 sh	—	—	4,655
2023-05-25	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+8,636 sh	—	—	8,636
2022-06-29	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+30K sh	—	—	30,000
2022-06-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2022-06-10	CSTLCASTLE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+830 sh	—	—	830
2022-06-10	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−830 sh	—	—	0
2022-06-02	CSTLCASTLE BIOSCIENCES INC · Stock option (right to buy)A Award	Director	AAward	+7,647 sh	—	—	7,647
2022-06-02	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+3,825 sh	—	—	3,825
2021-06-29	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+33.2K sh	—	—	33,237
2021-06-10	CSTLCASTLE BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+830 sh	—	—	830
2021-06-10	CSTLCASTLE BIOSCIENCES INC · Stock option (right to buy)A Award	Director	AAward	+3,379 sh	—	—	3,379
2020-07-27	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+38K sh	—	—	37,965
2020-06-04	CSTLCASTLE BIOSCIENCES INC · Stock option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2020-02-19	EXASEXACT SCIENCES CORP · Stock Option (right to buy)M Exercise/Conversion	General Manager - Diagnostics	MExercise/Conversion	−13.4K sh	—	—	0
2020-02-19	EXASEXACT SCIENCES CORP · Stock Option (right to buy)M Exercise/Conversion	General Manager - Diagnostics	MExercise/Conversion	−3,934 sh	—	—	0
2020-02-19	EXASEXACT SCIENCES CORPS Sale	General Manager - Diagnostics	SSale	−27.4K sh	$100.00	−$2.74M	10,194
2020-02-19	EXASEXACT SCIENCES CORPM Exercise/Conversion	General Manager - Diagnostics	MExercise/Conversion	+13.4K sh	$35.91	+$482K	37,550
2020-02-19	EXASEXACT SCIENCES CORPM Exercise/Conversion	General Manager - Diagnostics	MExercise/Conversion	+3,934 sh	$35.28	+$139K	24,128

Recent filings

Accepted (ET)
Jul 314
Cole G Bradley0001337798-26-000004
SEC(opens sec.gov)
Jun 24
Cole G Bradley0001337798-26-000002
SEC(opens sec.gov)
Jun 14
Cole G Bradley0001447362-26-000013
SEC(opens sec.gov)
May 274
Cole G Bradley0001447362-26-000011
SEC(opens sec.gov)
Mar 94
Cole G Bradley0001447362-26-000008
SEC(opens sec.gov)
Jun 54
Cole G Bradley0001415889-25-015805
SEC(opens sec.gov)
May 234
Cole G Bradley0001447362-25-000087
SEC(opens sec.gov)

Companies

Address

C/O KINIKSA PHARMACEUTICALS INT'L 105 PICCADILLY, SECOND FLOOR

LONDON, W1J 7NJ